SERA PROGNOSTICS, INC.·4

Jul 21, 6:01 PM ET

CRITCHFIELD GREGORY C 4

4 · SERA PROGNOSTICS, INC. · Filed Jul 21, 2021

Insider Transaction Report

Form 4
Period: 2021-07-19
Transactions
  • Conversion

    Class A Common Stock

    2021-07-19+11,880761,488 total
  • Conversion

    Series A-2 Preferred Stock

    2021-07-1934,3830 total
    Class A Common Stock (34,383 underlying)
  • Conversion

    Series B-2 Preferred Stock

    2021-07-1911,8800 total
    Class A Common Stock (11,880 underlying)
  • Conversion

    Series D Preferred Stock

    2021-07-1928,7300 total
    Class A Common Stock (28,730 underlying)
  • Conversion

    Class A Common Stock

    2021-07-19+34,383744,355 total
  • Conversion

    Class A Common Stock

    2021-07-19+5,253749,608 total
  • Conversion

    Class A Common Stock

    2021-07-19+4,727766,215 total
  • Conversion

    Class A Common Stock

    2021-07-19+28,730794,945 total
  • Conversion

    Series B-1 Preferred Stock

    2021-07-195,2530 total
    Class A Common Stock (5,253 underlying)
  • Conversion

    Series C-1 Preferred Stock

    2021-07-194,7270 total
    Class A Common Stock (4,727 underlying)
Footnotes (7)
  • [F1]The Issuer's Series A-2 Preferred Stock is convertible at the option of a holder at any time into shares of the Issuer's Class A Common Stock at a conversion price, as adjusted to reflect the Issuer's recent 1-for-0.481 reverse stock split, of $5.20 per share. The Series A-2 Preferred Stock has no expiration date.
  • [F2]Includes 630,832 shares of Class A Common Stock directly held by The Gregory C. Critchfield & Trust. Dr. Critchfield is a Trustee of the Gregory C. Critchfield & Trust. Dr. Critchfield, in such capacity, may be deemed to indriectly beneficially own the securities owned by the trust except to the extent of his pecuniary interest therein, if any.
  • [F3]The Issuer's Series B-1 Preferred Stock is convertible at the option of a holder at any time into shares of the Issuer's Class A Common Stock at a conversion price, as adjusted to reflect the Issuer's recent 1-for-0.481 reverse stock split, of $5.20 per share. The Series B-1 Preferred Stock has no expiration date.
  • [F4]The Issuer's Series B-2 Preferred Stock is convertible at the option of a holder at any time into shares of the Issuer's Class A Common Stock at a conversion price, as adjusted to reflect the Issuer's recent 1-for-0.481 reverse stock split, of $8.32 per share. The Series B-2 Preferred Stock has no expiration date.
  • [F5]The Issuer's Series C-1 Preferred Stock is convertible at the option of a holder at any time into shares of the Issuer's Class A Common Stock at a conversion price, as adjusted to reflect the Issuer's recent 1-for-0.481 reverse stock split, of $12.37 per share. The Series C-1 Preferred Stock has no expiration date.
  • [F6]The Issuer's Series D Preferred Stock is convertible at the option of a holder at any time into shares of the Issuer's Class A Common Stock at a conversion price, as adjusted to reflect the Issuer's recent 1-for-0.481 reverse stock split, of $9.02 per share. The Series D Preferred Stock has no expiration date.
  • [F7]The shares of preferred stock automatically converted into the Issuer's Class A Common Stock in accordance with the Issuer's Restated Certificate of Incorporation, as amended, immediately upon completion of the Issuer's initial public offering, which became effective on July 19, 2021.

Documents

1 file
  • 4
    tm2122781-3_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT